Dr. Stephanie Sterling, section chief for infectious diseases and hospital epidemiologist NYU Langone Hospital—Brooklyn and co-leader of the Vaccine Center there.
Photo: NYU Langone Staff
AstraZeneca is now the latest pharmaceutical company to say its coronavirus disease (COVID-19) vaccine is showing promising results, and part of this study is taking place in Brooklyn.
A new clinical trial for AstraZeneca’s vaccine candidate is currently underway at the brand new Vaccine Center at NYU Langone Hospital—Brooklyn.
News 12 Brooklyn’s cameras were present when Edwin Ruiz joined a growing number of volunteers in receiving his first injection.
“It’s very reassuring that they’re seeing great efficacy that is well beyond the 50 percent that our FDA says we’re looking for to help promote a vaccine,” says Stephanie Sterling, MD, section chief for infectious diseases and hospital epidemiologist NYU Langone Hospital—Brooklyn and co-leader of the Vaccine Center there.
Watch the report from News 12 Brooklyn.
